Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical losartan after penetrating keratoplasty for corneal scarring
IRCT20261002071258N1Phase 3Recruiting
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in corneal fibrosis comparing Topical losartan with Placebo (2 arms). Primary endpoint: Change in corneal scar or opacity severity. Started Oct 2026; status: recruiting.
02
Drugs
losartan
03
Conditions
corneal fibrosis
Beyond the preview
Go deeper on IRCT20261002071258N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261002071258N1.